Eli Lilly & Co. (LLY) Tops Q4 EPS by 34c, Revenue Beats, Offers Guidance
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,180.16 -2.25%
Financial Fact:
Cost of sales, operating expenses, and other-net: 4.22B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Cost of sales, operating expenses, and other-net: 4.22B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $2.49, $0.34 better than the analyst estimate of $2.15. Revenue for the quarter came in at $8 billion versus the consensus estimate of $6.74 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2022 EPS of $8.50-$8.65, versus the consensus of $7.54.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
